Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 Test Kit) and flow cytometry

Mark W. Moss, Anthony V. Carella, Viera Provost, Thomas C Quinn

Research output: Contribution to journalArticle

Abstract

Currently, CD4+ lymphocyte counts are one of the most widely used surrogate markers for monitoring disease progression in and initiating therapy for human immunodeficiency virus-infected individuals. However, the process of obtaining lymphocyte subset counts can be complex and expensive, often rendering the test inaccessible to many patients. In contrast to standard laser-based flow cytometry, the TRAx CD4 Test Kit utilizes an enzyme-linked immunoassay format to provide CD4+ lymphocyte counts by a simple and more cost-effective means. In order to evaluate the utility of the TRAx CD4+ assay in comparison with flow cytometry, heparinized blood samples were drawn from 188 infected and uninfected adult patients and 24 infected pediatric patients and evaluated by both assays. The correlation coefficient for all adult individuals tested was 0.94, and the mean absolute counts (in cells per milliliter, ± standard deviation) were 510 ± 358 for TRAx and 480 ± 361 for flow cytometry. The correlation for the pediatric group was 0.93, with mean absolute counts of 956 ± 767 for TRAx and 1,521 ± 1,438 for flow cytometry. Overall the TRAx CD4 Test Kit performed well in comparison to flow cytometry, and its lower cost and ease of use make it an encouraging alternative for the routine determination of CD4+ lymphocyte counts.

Original languageEnglish (US)
Pages (from-to)371-373
Number of pages3
JournalClinical and Diagnostic Laboratory Immunology
Volume3
Issue number4
StatePublished - 1996

Fingerprint

Lymphocytes
Flow cytometry
CD4 Lymphocyte Count
Immunoenzyme Techniques
Flow Cytometry
Enzymes
Pediatrics
Assays
Costs and Cost Analysis
Lymphocyte Subsets
Lymphocyte Count
Viruses
Disease Progression
Costs
Lasers
Blood
Cell Count
Biomarkers
HIV
Monitoring

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Clinical Biochemistry
  • Immunology

Cite this

Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 Test Kit) and flow cytometry. / Moss, Mark W.; Carella, Anthony V.; Provost, Viera; Quinn, Thomas C.

In: Clinical and Diagnostic Laboratory Immunology, Vol. 3, No. 4, 1996, p. 371-373.

Research output: Contribution to journalArticle

@article{cf8ca749b0974dcf8f2e6c0a3313621c,
title = "Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 Test Kit) and flow cytometry",
abstract = "Currently, CD4+ lymphocyte counts are one of the most widely used surrogate markers for monitoring disease progression in and initiating therapy for human immunodeficiency virus-infected individuals. However, the process of obtaining lymphocyte subset counts can be complex and expensive, often rendering the test inaccessible to many patients. In contrast to standard laser-based flow cytometry, the TRAx CD4 Test Kit utilizes an enzyme-linked immunoassay format to provide CD4+ lymphocyte counts by a simple and more cost-effective means. In order to evaluate the utility of the TRAx CD4+ assay in comparison with flow cytometry, heparinized blood samples were drawn from 188 infected and uninfected adult patients and 24 infected pediatric patients and evaluated by both assays. The correlation coefficient for all adult individuals tested was 0.94, and the mean absolute counts (in cells per milliliter, ± standard deviation) were 510 ± 358 for TRAx and 480 ± 361 for flow cytometry. The correlation for the pediatric group was 0.93, with mean absolute counts of 956 ± 767 for TRAx and 1,521 ± 1,438 for flow cytometry. Overall the TRAx CD4 Test Kit performed well in comparison to flow cytometry, and its lower cost and ease of use make it an encouraging alternative for the routine determination of CD4+ lymphocyte counts.",
author = "Moss, {Mark W.} and Carella, {Anthony V.} and Viera Provost and Quinn, {Thomas C}",
year = "1996",
language = "English (US)",
volume = "3",
pages = "371--373",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 Test Kit) and flow cytometry

AU - Moss, Mark W.

AU - Carella, Anthony V.

AU - Provost, Viera

AU - Quinn, Thomas C

PY - 1996

Y1 - 1996

N2 - Currently, CD4+ lymphocyte counts are one of the most widely used surrogate markers for monitoring disease progression in and initiating therapy for human immunodeficiency virus-infected individuals. However, the process of obtaining lymphocyte subset counts can be complex and expensive, often rendering the test inaccessible to many patients. In contrast to standard laser-based flow cytometry, the TRAx CD4 Test Kit utilizes an enzyme-linked immunoassay format to provide CD4+ lymphocyte counts by a simple and more cost-effective means. In order to evaluate the utility of the TRAx CD4+ assay in comparison with flow cytometry, heparinized blood samples were drawn from 188 infected and uninfected adult patients and 24 infected pediatric patients and evaluated by both assays. The correlation coefficient for all adult individuals tested was 0.94, and the mean absolute counts (in cells per milliliter, ± standard deviation) were 510 ± 358 for TRAx and 480 ± 361 for flow cytometry. The correlation for the pediatric group was 0.93, with mean absolute counts of 956 ± 767 for TRAx and 1,521 ± 1,438 for flow cytometry. Overall the TRAx CD4 Test Kit performed well in comparison to flow cytometry, and its lower cost and ease of use make it an encouraging alternative for the routine determination of CD4+ lymphocyte counts.

AB - Currently, CD4+ lymphocyte counts are one of the most widely used surrogate markers for monitoring disease progression in and initiating therapy for human immunodeficiency virus-infected individuals. However, the process of obtaining lymphocyte subset counts can be complex and expensive, often rendering the test inaccessible to many patients. In contrast to standard laser-based flow cytometry, the TRAx CD4 Test Kit utilizes an enzyme-linked immunoassay format to provide CD4+ lymphocyte counts by a simple and more cost-effective means. In order to evaluate the utility of the TRAx CD4+ assay in comparison with flow cytometry, heparinized blood samples were drawn from 188 infected and uninfected adult patients and 24 infected pediatric patients and evaluated by both assays. The correlation coefficient for all adult individuals tested was 0.94, and the mean absolute counts (in cells per milliliter, ± standard deviation) were 510 ± 358 for TRAx and 480 ± 361 for flow cytometry. The correlation for the pediatric group was 0.93, with mean absolute counts of 956 ± 767 for TRAx and 1,521 ± 1,438 for flow cytometry. Overall the TRAx CD4 Test Kit performed well in comparison to flow cytometry, and its lower cost and ease of use make it an encouraging alternative for the routine determination of CD4+ lymphocyte counts.

UR - http://www.scopus.com/inward/record.url?scp=0029862203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029862203&partnerID=8YFLogxK

M3 - Article

C2 - 8807198

AN - SCOPUS:0029862203

VL - 3

SP - 371

EP - 373

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 4

ER -